Paper17570972
Leishmania tropica infection, in comparison to Leishmania major, induces lower delayed type hypersensitivity in BALB/c mice.
Mahmoudzadeh-Niknam H and 2 others. Korean J Parasitol, 2007. Cited by 13 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Leishmania tropica infection, in comparison to Leishmania major, induces lower delayed type hypersensitivity in BALB/c mice. Papers, record 17570972. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17570972
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Leishmania tropica infection, in comparison to Leishmania major, induces lower delayed type hypersensitivity in BALB/c mice.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hypersensitivity, Delayed | Major topic |
| Leishmania major | Major topic |
| Leishmania tropica | Major topic |
| Leishmaniasis, Cutaneous | Major topic |
| Animals | |
| Disease Models, Animal | |
| Ear | |
| Female | |
| Foot | |
| Mice | |
| Mice, Inbred BALB C |
Source PubMed
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11,801,669 | CD28 costimulation and parasite dose combine to influence the susceptibility of BALB/c mice to infection with Leishmania major. | J Immunol | 2002 | https://conductscience.org/library/papers/11801669 | PubMed |
| 2 | 9,676,711 | Leishmania tropica: the identification and purification of metacyclic promastigotes and use in establishing mouse and hamster models of cutaneous and visceral disease. | Exp Parasitol | 1998 | https://conductscience.org/library/papers/9676711 | PubMed |
| 3 | 15,172,223 | Leishmania tropica: cysteine proteases are essential for growth and pathogenicity. | Exp Parasitol | 2004 | https://conductscience.org/library/papers/15172223 | PubMed |
| 4 | 15,196,239 | Mast cells at the host-pathogen interface: host-protection versus immune evasion in leishmaniasis. | Clin Exp Immunol | 2004 | https://conductscience.org/library/papers/15196239 | PubMed |
| 5 | 15,271,920 | Inbred strains derived from feral mice reveal new pathogenic mechanisms of experimental leishmaniasis due to Leishmania major. | Infect Immun | 2004 | https://conductscience.org/library/papers/15271920 | PubMed |
| 6 | 6,447,751 | Immunological regulation of experimental cutaneous leishmaniasis. III. Nature and significance of specific suppression of cell-mediated immunity in mice highly susceptible to Leishmania tropica. | J Exp Med | 1980 | https://conductscience.org/library/papers/6447751 | PubMed |
| 7 | 3,160,663 | Specific suppressor T cells for delayed-type hypersensitivity in susceptible mice immunized against cutaneous leishmaniasis. | Infect Immun | 1985 | https://conductscience.org/library/papers/3160663 | PubMed |
| 8 | 3,160,786 | Prophylactic immunization against experimental leishmaniasis. V. Mechanism of the anti-protective blocking effect induced by subcutaneous immunization against Leishmania major infection. | J Immunol | 1985 | https://conductscience.org/library/papers/3160786 | PubMed |
| 9 | 3,818,088 | Induction of delayed-type hypersensitivity to Leishmania major and the concomitant acceleration of disease development in progressive murine cutaneous leishmaniasis. | Infect Immun | 1987 | https://conductscience.org/library/papers/3818088 | PubMed |
| 10 | 3,562,057 | The correlation between delayed hypersensitivity, lymphocyte activation and protective immunity in experimental murine leishmaniasis. | Parasite Immunol | 1987 | https://conductscience.org/library/papers/3562057 | PubMed |
| 11 | 3,295,049 | Distinctive cellular immunity in genetically susceptible BALB/c mice recovered from Leishmania major infection or after subcutaneous immunization with killed parasites. | J Immunol | 1987 | https://conductscience.org/library/papers/3295049 | PubMed |
| 12 | 1,636,090 | Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. | Science | 1992 | https://conductscience.org/library/papers/1636090 | PubMed |
| 13 | 8,249,076 | The clinical and immunological spectrum of American cutaneous leishmaniasis. | Trans R Soc Trop Med Hyg | 1993 | https://conductscience.org/library/papers/8249076 | PubMed |
| 14 | 8,932,762 | Leishmania major: effect of infectious dose on T cell subset development in BALB/c mice. | Exp Parasitol | 1996 | https://conductscience.org/library/papers/8932762 | PubMed |
| 15 | 14,527,520 | Intradermal inoculations of low doses of Leishmania major and Leishmania amazonensis metacyclic promastigotes induce different immunoparasitic processes and status of protection in BALB/c mice. | Int J Parasitol | 2003 | https://conductscience.org/library/papers/14527520 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,181,203 | Evaluation of Apoptotic Effect of Transgenic Leishmania tropica Expressing MLLO-Bax-Smac Fusion Gene in Infected Macrophages, an In Vitro Study. | Iran J Parasitol | 2025 | https://conductscience.org/library/papers/41181203 | PubMed |
| 39,528,528 | Expression of key cytokines in dog macrophages infected by Leishmania tarentolae opening new avenues for the protection against Leishmania infantum. | Sci Rep | 2024 | https://conductscience.org/library/papers/39528528 | PubMed |
| 36,296,160 | Interspecies and Intrastrain Interplay among Leishmania spp. Parasites. | Microorganisms | 2022 | https://conductscience.org/library/papers/36296160 | PubMed |
| 30,248,142 | Vaccination with whole-cell killed or recombinant leishmanial protein and toll-like receptor agonists against Leishmania tropica in BALB/c mice. | PLoS One | 2018 | https://conductscience.org/library/papers/30248142 | PubMed |
| 26,334,763 | A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous Leishmaniasis. | PLoS Negl Trop Dis | 2015 | https://conductscience.org/library/papers/26334763 | PubMed |
| 23,467,583 | The route of Leishmania tropica infection determines disease outcome and protection against Leishmania major in BALB/c mice. | Korean J Parasitol | 2013 | https://conductscience.org/library/papers/23467583 | PubMed |
| 22,961,311 | Antineoplastic drug, carboplatin, protects mice against visceral leishmaniasis. | Parasitol Res | 2013 | https://conductscience.org/library/papers/22961311 | PubMed |
| 18,165,706 | Viscerotropic growth pattern of Leishmania tropica in BALB/c mice is suggestive of a murine model for human viscerotropic leishmaniasis. | Korean J Parasitol | 2007 | https://conductscience.org/library/papers/18165706 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17570972
GET https://conductscience.org/api/papers/v1/17570972/authors